GOLDMAN SACHS GROUP INC - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 248 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2022. The put-call ratio across all filers is 52.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$19,672,629
-9.7%
1,497,156
-13.4%
0.00%0.0%
Q2 2023$21,788,021
-26.3%
1,729,208
-23.6%
0.00%
-33.3%
Q1 2023$29,548,280
-23.9%
2,264,236
+2.9%
0.01%
-33.3%
Q4 2022$38,823,893
-0.9%
2,200,901
-14.5%
0.01%0.0%
Q3 2022$39,185,000
-7.5%
2,572,879
-9.9%
0.01%
-10.0%
Q2 2022$42,361,000
-34.6%
2,856,466
-0.7%
0.01%
-28.6%
Q1 2022$64,757,000
+2.4%
2,875,527
-16.1%
0.01%
+7.7%
Q4 2021$63,229,000
+59.9%
3,427,095
+15.9%
0.01%
+62.5%
Q3 2021$39,538,000
-29.1%
2,957,201
-1.9%
0.01%
-33.3%
Q2 2021$55,775,000
+60.9%
3,013,235
+30.6%
0.01%
+33.3%
Q1 2021$34,654,000
+2.5%
2,307,968
-1.4%
0.01%0.0%
Q4 2020$33,797,000
+66.4%
2,340,509
-6.2%
0.01%
+50.0%
Q3 2020$20,313,000
+10.8%
2,495,433
-7.9%
0.01%0.0%
Q2 2020$18,341,000
+1.1%
2,709,040
+5.1%
0.01%0.0%
Q1 2020$18,142,000
-66.1%
2,577,000
-52.7%
0.01%
-57.1%
Q4 2019$53,495,000
-20.0%
5,450,358
-10.5%
0.01%
-26.3%
Q3 2019$66,837,000
-25.0%
6,087,113
-20.5%
0.02%
-26.9%
Q2 2019$89,068,000
+33.7%
7,658,443
+9.7%
0.03%
+30.0%
Q1 2019$66,621,000
-12.2%
6,983,430
-11.3%
0.02%
-16.7%
Q4 2018$75,888,000
-28.7%
7,872,163
+5.4%
0.02%
-11.1%
Q3 2018$106,387,000
-11.7%
7,465,730
-25.6%
0.03%
-18.2%
Q2 2018$120,479,000
+27.3%
10,039,865
+31.0%
0.03%
+37.5%
Q1 2018$94,618,000
-17.0%
7,661,375
-2.3%
0.02%
-11.1%
Q4 2017$114,059,000
-11.1%
7,839,141
-13.1%
0.03%
-12.9%
Q3 2017$128,367,000
+37.8%
9,020,931
+23.5%
0.03%
+29.2%
Q2 2017$93,182,000
+198.3%
7,302,737
+196.4%
0.02%
+200.0%
Q1 2017$31,242,000
+150.7%
2,463,863
+101.8%
0.01%
+100.0%
Q4 2016$12,464,000
-75.1%
1,220,682
-67.9%
0.00%
-73.3%
Q3 2016$50,031,000
-10.2%
3,798,927
-13.4%
0.02%
-16.7%
Q2 2016$55,694,000
-28.0%
4,385,351
-25.1%
0.02%
-28.0%
Q1 2016$77,391,000
+7.4%
5,858,446
+25.0%
0.02%
+8.7%
Q4 2015$72,060,000
-2.2%
4,685,287
-21.2%
0.02%
-8.0%
Q3 2015$73,685,000
-67.2%
5,942,370
-63.9%
0.02%
-64.3%
Q2 2015$224,883,000
-13.6%
16,438,836
-24.4%
0.07%
-16.7%
Q1 2015$260,183,000
+25.1%
21,754,376
+33.5%
0.08%
+27.3%
Q4 2014$208,056,000
+85.5%
16,292,598
+94.9%
0.07%
+83.3%
Q3 2014$112,132,000
-23.9%
8,358,731
-8.9%
0.04%
-21.7%
Q2 2014$147,264,000
+9.2%
9,175,322
+22.7%
0.05%
+4.5%
Q1 2014$134,834,000
+9.4%
7,478,273
-6.2%
0.04%
+7.3%
Q4 2013$123,216,000
+26.6%
7,970,007
+21.8%
0.04%
+13.9%
Q3 2013$97,295,000
+3.1%
6,543,045
-10.3%
0.04%0.0%
Q2 2013$94,406,000
+2390.3%
7,295,759
+1713.0%
0.04%
+1700.0%
Q4 2012$3,791,000
+37.3%
402,423
+81.0%
0.00%
+100.0%
Q3 2012$2,762,000
-48.7%
222,339
-54.8%
0.00%
-50.0%
Q2 2012$5,379,000
+65.6%
492,117
+151.5%
0.00%
+100.0%
Q1 2012$3,248,000195,6530.00%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q2 2022
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders